Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
122.26
+0.40 (0.33%)
At close: Feb 20, 2026, 4:00 PM EST
122.10
-0.16 (-0.13%)
After-hours: Feb 20, 2026, 7:58 PM EST

Merck & Co. Revenue

In the year 2025, Merck & Co. had annual revenue of $65.01B with 1.31% growth. Merck & Co. had revenue of $16.40B in the quarter ending December 31, 2025, with 4.97% growth.

Revenue (ttm)
$65.01B
Revenue Growth
+1.31%
P/S Ratio
4.67
Revenue / Employee
$866,813
Employees
75,000
Market Cap
303.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.01B843.00M1.31%
Dec 31, 202464.17B4.05B6.74%
Dec 31, 202360.12B832.00M1.40%
Dec 31, 202259.28B10.58B21.72%
Dec 31, 202148.70B7.19B17.31%
Dec 31, 202041.52B2.40B6.13%
Dec 31, 201939.12B-3.17B-7.50%
Dec 31, 201842.29B2.17B5.41%
Dec 31, 201740.12B315.00M0.79%
Dec 31, 201639.81B309.00M0.78%
Dec 31, 201539.50B-2.74B-6.48%
Dec 31, 201442.24B-1.80B-4.08%
Dec 31, 201344.03B-3.23B-6.84%
Dec 31, 201247.27B-780.00M-1.62%
Dec 31, 201148.05B2.06B4.48%
Dec 31, 201045.99B18.56B67.66%
Dec 31, 200927.43B3.58B15.00%
Dec 31, 200823.85B-347.70M-1.44%
Dec 31, 200724.20B13.60B128.41%
Dec 31, 200610.59B1.09B11.42%
Dec 31, 20059.51B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson94.19B
Pfizer62.58B
AbbVie61.16B
AstraZeneca58.74B
Novartis AG56.67B
Sanofi54.85B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
Revenue Rankings